As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. The bioburden testing market is witnessing growth due to factors such as growth in the medical devices, ...